TABLE 2.

The effective dosages and therapeutic durations of G6PD inhibitors in animal models of cancer.

Inhibitors	Organism	Dose	Duration	Injection type	References
6-An	Mouse	4 mg/kg/3d	-	Intraperitoneal injection	Sun et al., (2021b)
	Mouse	23 mg/kg/d	-	Intraperitoneal injection	Zhang et al., (2020)
	Mouse	20 mg/kg/10d	40d	Intraperitoneal injection	Best et al., (2019)
	Mouse	5 mg/kg/day	23d	Intraperitoneal injection	Poulain et al., (2017)
DHEA	Mouse	80 mg/kg/3d	20d	Intraperitoneal injection	Wang et al., (2020)
NEOU	Mouse	1.5 mg/kg/d	21d	Intraperitoneal injection	Kitagawa et al., (2021)
	Mouse	1.5 mg/kg/d	28d	Intraperitoneal injection	Joshi et al., (2020)
Epi	Rats	30 mg/kg/d	28d	Intraperitoneal injection	Dhagia et al., (2021)
Polydatin	Mouse	5 mg/kg/d	14d	Intraperitoneal injection	Su et al., (2021)
	Mouse	100 mg/kg	-	Intraperitoneal injection	Mele et al., (2018)